Of note, in the lung cancer model, 12 weeks of exposure to these epigenetic modulators increased the number of activated, CD8+IFN‐γ+ tumor T cells, but this change was not evident at 4 weeks [24], which was the length of time we exposed mice to these agents to observe a significant difference in tumor growth. This evidence concerns the gene IFNG and lung carcinoma.